Moody’s Co. (NYSE:MCO) Receives Average Rating of “Buy” from Analysts

Shares of Moody’s Co. (NYSE:MCO – Get Rating) have received an average recommendation of “Hold” from the fourteen research firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $348.67.

Incyte Co. (NASDAQ:INCY) Receives Consensus Rating of “Buy” from Analysts

Incyte Co. (NASDAQ:INCY – Get Rating) has been assigned a consensus rating of “Buy” from the fifteen analysts that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $86.92.

SoFi Technologies, Inc. (NASDAQ:SOFI) CEO Anthony Noto Buys 21,750 Shares

SoFi Technologies, Inc. (NASDAQ:SOFI) CEO Anthony Noto bought 21,750 shares of the business’s stock in a transaction on Monday, June 6th. The stock was bought at an average cost of $6.90 per share, with a total value of $150,075.00. Following the completion of the purchase, the chief executive officer now directly owns 3,369,014 shares in the company, valued at $23,246,196.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

$1.08 Earnings Per Share Expected for Copart, Inc. (NASDAQ:CPRT) This Quarter

Brokerages expect Copart, Inc. (NASDAQ:CPRT – Get Rating) to announce $1.08 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Copart’s earnings. The lowest EPS estimate is $1.06 and the highest is $1.10. Copart reported earnings per share of $1.03 in the same quarter last year, which suggests a positive year-over-year growth rate of 4.9%. The business is scheduled to announce its next quarterly earnings results on Monday, January 1st.

Prometheus Biosciences, Inc. (NASDAQ:RXDX) Receives Average Recommendation of “Buy” from Analysts

Prometheus Biosciences, Inc. (NASDAQ:RXDX – Get Rating) has received an average recommendation of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $52.57.

Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of “Buy” from Analysts

Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Rating) have received an average recommendation of “Buy” from the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $49.13.

UserTesting Inc (NYSE:USER) Given Average Recommendation of “Buy” by Analysts

Shares of UserTesting Inc (NYSE:USER – Get Rating) have received an average recommendation of “Buy” from the twelve analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $13.60.

error: Content is protected !!